메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

EDAN Expands U.S. Operations with New Manufacturing Hub

Facility marks EDAN's 30th anniversary and kickstarts global supply chain ecosystem SAN DIEGO, Oct. 9, 2025 -- Edan Instruments, Inc. (300206.SZ), a global leader in medical device innovation, announced the official opening of its new U.S. manufacturing hub in San Diego, California, on September 30, 2025. Building on more than 15 years of local presence through its San Diego office, the milestone marks EDAN Diagnostics, Inc.'s first U.S.-based production site and strengthens the company's presence in the region, enhancing its ability to support healthcare providers with advance
- 김갑성 기자
- 2025-10-09 06:53
명상이 정량화 가능한 성과가 되는 시대 -- 일본 최초의 '정량화 명상 챌린지'

도쿄, 2025년 10월 8일 -- 세계명상연맹(World Meditation League•WML)과 올히어(All Here)가 일본 도쿄 핫포엔(Happo-en) 정원에서 일본 최초의 도쿄 정량화 명상 챌린지(Tokyo Quantified Meditation Challenge)를 선보이며 명상이 새로운 시대에 접어들었다. 이와 같은 전례 없는 행사는 명상을 개인의 내면 성찰에서 벗어나 신경과학을 통해 측정과 관찰이 가능한 경쟁적인 분야로 변화시켰다. 행사에서 참가자의 두뇌 활동, 집중도, 자기 인식, 내면의 고요가 정량화된 데이터로 화면에 시각적으로 표시되자 관객들은 처음으로 명상의 효과를 실시간으로 목격했다. 기술 × 건축 × 자연 — 쿠마 겐고와 올히어가 개발한 명상 캡슐 공개 오후 행사는 세계적으로 유명한 건축가 쿠마 겐고(Kengo Kuma)의 발표로 시작됐다. 그는 올히어가 개발한 몰입형 명상 XR 플랫폼 젠부 코코(Zenbu Koko)를 공개했다. 쿠마 겐고는 "나는 오래전부터 건축, 공허함, 자연을 매끄럽게 연결하고 싶었다
- 김갑성 기자
- 2025-10-09 04:59
Breakthrough Lectures to Headline the 2025 World Congress of Neurology in Seoul

SEOUL, South Korea, Oct. 9, 2025 -- The World Federation of Neurology (WFN) and the Korean Neurological Association (KNA) will host the XXVII World Congress of Neurology (WCN) in Seoul, South Korea, from Oct. 12-15, 2025. WCN is a major, biennial conference that brings together world-class neurologists, experts, researchers, and clinicians from across the globe to showcase the latest advances in brain science, neurology, and patient care. The congress theme, "The Soul of Neurological Innovation," is exemplified through an elite Scientific Program featuring some of the
- 김갑성 기자
- 2025-10-09 04:41
TCI Biotech Releases 2024 ESG Report, Showcasing Brand Transformation, Global Sustainability Commitments, and Award-Winning Impact

SALT LAKE CITY, Oct. 8, 2025 -- TCI Biotech, a global biotechnology leader in health and wellness, today announced the release of its 2024 Environmental, Social, and Governance (ESG) Report, marking a milestone year of brand renewal, international sustainability recognition, and measurable ESG results. Alongside the report, TCI announced top honors at the 2025 Green World Awards and the International CSR Excellence Awards, reaffirming its position as a global sustainability innovator serving 67 countries worldwide. Brand Renewal and Global Vision In 2025, TCI Biotech intr
- 김갑성 기자
- 2025-10-08 23:00
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025

BARCELONA, Spain, Oct. 8, 2025 -- During the 2025 Annual Congress of the European Association of Nuclear Medicine (EANM 2025), C-Ray Therapeutics (Shanghai) Co., Ltd. ("C-Ray Shanghai"), a company dedicated to the development of innovative targeted radiopharmaceuticals, announced promising new clinical results for its lead program 225Ac-PSMA-CY313 in the treatment of metastatic castration-resistant prostate cancer (mCRPC). These data, highlighted in two Top Rated Oral Presentations, provide early clinical evidence of the therapy's significant potential and favorable s
- 김갑성 기자
- 2025-10-08 22:20
India's No: 1 Ranked Institute, IIT Madras & Danish University Study reveals Genetic 'Switches' that can transform Disease Research

CHENNAI, India, Oct. 8, 2025 -- India's No:1 Ranked Institute, the Indian Institute of Technology Madras, and Danish researchers have shown how interactions between genetic variants can act like 'switches' to unlock hidden cellular pathways. The findings of this research, undertaken jointly with the Technical University of Denmark, were published in a research paper in the prestigious, internationally-renowned Nature Communications journal (DOI: 10.1038/s41467-025-63306-4), an open-access journal also published by Springer Nature. In this study, the researchers, using sy
- 김갑성 기자
- 2025-10-08 21:48
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street

NEW YORK, Oct. 8, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street Ashley Mastronardi delivers the pre-market update on October 8th Stocks are fractionally higher Wednesday as traders await minutes from the Federal Reserve's latest meeting. The gains come after the S&P 500 snapped a seven-day winning streak
- 황정호 기자
- 2025-10-08 21:20
Public Interest Registry Unveils Winners of 7th Annual .ORG Impact Awards at DC Ceremony Hosted by Grammy-Award Winning Artist Common

The Fund for Congolese Women named 2025 .ORG of the Year, selected from nearly 3,000 applicants from more than 120 countries WASHINGTON, Oct. 8, 2025 -- Public Interest Registry (PIR), the people behind the .ORG domain, announced the winners of the 2025 ORG Impact Awards, an annual celebration recognizing and rewarding outstanding mission-driven individuals and organizations from around the world for their positive contributions to society. The seven winners — selected from nearly 3,000 applicants from more than 120 countries — were announced live at the awards ceremony, which
- 김갑성 기자
- 2025-10-08 21:00
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System

〜Driving Technology Transfer and Test Manufacturing Following Regulatory Approval to Launch Company-Led af-001 Trial〜 TOKYO, Oct. 8, 2025 -- Alpha Fusion Inc. (Alpha Fusion) is proud to announce a joint initiative with the Kobe City Medical Center General Hospital (KCGH) to establish a domestic supply system for investigational drugs utilizing Astatine-211 (At-211). This collaboration significantly advances the foundational work for what is expected to be the world's first company-sponsored clinical trial using At-211 (as of September 2025). KCGH has secured usage approv
- 김갑성 기자
- 2025-10-08 21:00
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

GUANGZHOU, China, Oct. 8, 2025 -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing of its initial public offering (the "Offering") of 5,000,004 American Depositary Shares ("ADSs") at a public offering price of US$4.00 per ADS. Six ADSs represent one Class A ordinary share, par value US$0.0001 per share, of the Company. The ADSs have been approved for listing on the Nasdaq Global Market and are expected to commence trading on October 8, 2025 under the t
- 김갑성 기자
- 2025-10-08 20:00

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-11-04_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 05일 01시 20분